These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 16533773)
1. Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer. Grabsch H; Dattani M; Barker L; Maughan N; Maude K; Hansen O; Gabbert HE; Quirke P; Mueller W Clin Cancer Res; 2006 Mar; 12(5):1494-500. PubMed ID: 16533773 [TBL] [Abstract][Full Text] [Related]
2. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation. Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541 [TBL] [Abstract][Full Text] [Related]
3. Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN. Beggs AD; Domingo E; McGregor M; Presz M; Johnstone E; Midgley R; Kerr D; Oukrif D; Novelli M; Abulafi M; Hodgson SV; Fadhil W; Ilyas M; Tomlinson IP Oncotarget; 2012 Nov; 3(11):1348-55. PubMed ID: 23154512 [TBL] [Abstract][Full Text] [Related]
4. [Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells]. Zhuang L; Yu SY; Huang XY; Cao Y; Xiong HH Ai Zheng; 2007 Jul; 26(7):724-9. PubMed ID: 17626748 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Xing J; Wu X; Vaporciyan AA; Spitz MR; Gu J Cancer; 2008 Jun; 112(12):2756-64. PubMed ID: 18457328 [TBL] [Abstract][Full Text] [Related]
6. Ku70/80 modulates ATM and ATR signaling pathways in response to DNA double strand breaks. Tomimatsu N; Tahimic CG; Otsuki A; Burma S; Fukuhara A; Sato K; Shiota G; Oshimura M; Chen DJ; Kurimasa A J Biol Chem; 2007 Apr; 282(14):10138-45. PubMed ID: 17272272 [TBL] [Abstract][Full Text] [Related]
7. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer. Ohrling K; Edler D; Hallström M; Ragnhammar P Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245 [TBL] [Abstract][Full Text] [Related]
8. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining. Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674 [TBL] [Abstract][Full Text] [Related]
9. Human syndromes with genomic instability and multiprotein machines that repair DNA double-strand breaks. De la Torre C; Pincheira J; López-Sáez JF Histol Histopathol; 2003 Jan; 18(1):225-43. PubMed ID: 12507302 [TBL] [Abstract][Full Text] [Related]
10. MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial. Levallet G; Dubois F; Fouret P; Antoine M; Brosseau S; Bergot E; Beau-Faller M; Gounant V; Brambilla E; Debieuvre D; Molinier O; Galateau-Sallé F; Mazieres J; Quoix E; Pujol JL; Moro-Sibilot D; Langlais A; Morin F; Westeel V; Zalcman G Oncotarget; 2017 Jan; 8(3):4313-4329. PubMed ID: 28008145 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. Lanza G; Gafà R; Santini A; Maestri I; Guerzoni L; Cavazzini L J Clin Oncol; 2006 May; 24(15):2359-67. PubMed ID: 16710035 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112 [TBL] [Abstract][Full Text] [Related]
13. The mismatch repair system is required for S-phase checkpoint activation. Brown KD; Rathi A; Kamath R; Beardsley DI; Zhan Q; Mannino JL; Baskaran R Nat Genet; 2003 Jan; 33(1):80-4. PubMed ID: 12447371 [TBL] [Abstract][Full Text] [Related]
14. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Tommiska J; Bartkova J; Heinonen M; Hautala L; Kilpivaara O; Eerola H; Aittomäki K; Hofstetter B; Lukas J; von Smitten K; Blomqvist C; Ristimäki A; Heikkilä P; Bartek J; Nevanlinna H Oncogene; 2008 Apr; 27(17):2501-6. PubMed ID: 17982490 [TBL] [Abstract][Full Text] [Related]
15. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways. Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326 [TBL] [Abstract][Full Text] [Related]
16. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin. Korabiowska M; Tscherny M; Stachura J; Ruschenburg I; Cordon-Cardo C; Brinck U In Vivo; 2002; 16(5):317-21. PubMed ID: 12494870 [TBL] [Abstract][Full Text] [Related]
17. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer. Alshareeda AT; Negm OH; Albarakati N; Green AR; Nolan C; Sultana R; Madhusudan S; Benhasouna A; Tighe P; Ellis IO; Rakha EA Breast Cancer Res Treat; 2013 Jun; 139(2):301-10. PubMed ID: 23624778 [TBL] [Abstract][Full Text] [Related]
19. Importance of MutL homologue MLH1 and MutS homologue MSH2 expression in Turkish patients with sporadic colorectal cancer. Erdamar S; Ucaryilmaz E; Demir G; Karahasanoglu T; Dogusoy G; Dirican A; Goksel S World J Gastroenterol; 2007 Sep; 13(33):4437-44. PubMed ID: 17724798 [TBL] [Abstract][Full Text] [Related]
20. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer. Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]